Average Co-Inventor Count = 5.10
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Patent Gmbh (12 from 2,943 patents)
2. Prexton Therapeutics Sa (1 from 4 patents)
13 patents:
1. 12415803 - Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)
2. 11098041 - Heteroaryl compounds as BTK inhibitors and uses thereof
3. 10253023 - Heteroaryl compounds as BTK inhibitors and uses thereof
4. 10233160 - Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors
5. 10080753 - Heterocyclic carboxamides as modulators of kinase activity
6. 10059671 - Positive allosteric modulators of mGluR3
7. 9981925 - Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors
8. 9879004 - Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4
9. 9708321 - Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4
10. 9440968 - Substituted pyrido[3,2-d]pyrimidines for treating cancer
11. 9139568 - Heterocyclic carboxamides as modulators of kinase activity
12. 9023847 - Azaheterocyclic compounds
13. 9006440 - Furopyridine derivatives